MyMD Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying

Comments
Loading...

The Dow Jones closed lower by over 1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

CommScope Holding

  • The Trade: CommScope Holding Company, Inc. COMM Director Claudius Watts IV acquired a total of 10,000 shares an average price of $3.43. To acquire these shares, it cost around $34,264.
  • What’s Happening: CommScope Holding announced it launched its SYSTIMAX Constellation edge-based platform.
  • What CommScope Holding Does: CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks.

LQR House

  • The Trade: LQR House Inc. LQR CEO Sean Dollinger acquired a total of 86,400 shares at an average price of $1.16. The insider spent around $100,288.
  • What’s Happening: LQR House reported the pricing of its initial public offering of 1,000,000 shares of common stock at a public offering price of $5.00 per share.
  • What LQR Does: LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space.

MyMD Pharmaceuticals

  • The Trade: MyMD Pharmaceuticals, Inc. MYMD Chief Legal Officer Paul Rivard acquired a total of 150,000 shares at an average price of $1.11. To acquire these shares, it cost around $166,500.
  • What’s Happening: The FDA accepted MyMD Pharmaceuticals' investigational new drug application for Phase 2 study of oral TNF-α inhibitor MYMD-1 in rheumatoid arthritis.
  • What MyMD Pharmaceuticals Does: MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms.

 

Check This Out: Wall Street's Most Accurate Analysts Say Hold These 3 Energy Stocks Delivering High-Dividend Yields

Don’t forget to check out our premarket coverage here

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!